Article Versions Notes

Imamura T, Narang N, Onoda H, Tanaka S, Ushijima R, Sobajima M, Fukuda N, Ueno H, Kinugawa K. Implications of Elevated Fibrosis-4 Index in Patients Receiving Trans-Catheter Aortic Valve Replacement. Journal of Clinical Medicine. 2021; 10(24):5778. https://doi.org/10.3390/jcm10245778

Imamura, Teruhiko, Nikhil Narang, Hiroshi Onoda, Shuhei Tanaka, Ryuichi Ushijima, Mitsuo Sobajima, Nobuyuki Fukuda, Hiroshi Ueno, and Koichiro Kinugawa. 2021. "Implications of Elevated Fibrosis-4 Index in Patients Receiving Trans-Catheter Aortic Valve Replacement" Journal of Clinical Medicine 10, no. 24: 5778. https://doi.org/10.3390/jcm10245778

Imamura, T., Narang, N., Onoda, H., Tanaka, S., Ushijima, R., Sobajima, M., Fukuda, N., Ueno, H., & Kinugawa, K. (2021). Implications of Elevated Fibrosis-4 Index in Patients Receiving Trans-Catheter Aortic Valve Replacement. Journal of Clinical Medicine, 10(24), 5778. https://doi.org/10.3390/jcm10245778